Cargando…

miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma

A multiple receptor tyrosine kinase inhibitor, sunitinib, is a first-line therapy for clear cell renal cell carcinoma (CCRCC). Unfortunately, it has the major challenges of low initial response rate and resistance after about one year of treatment. Here we evaluated a microRNA (miRNA) and its target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sang Eun, Kim, Wonju, Hong, Ji-Ye, Kang, Dayeon, Park, Seulki, Suh, Jungyo, You, Dalsan, Park, Yun-Yong, Suh, Nayoung, Hwang, Jung Jin, Kim, Choung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894382/ https://www.ncbi.nlm.nih.gov/pubmed/35241735 http://dx.doi.org/10.1038/s41598-022-07468-x

Ejemplares similares

Global knockdown of microRNAs affects the expression of growth factors and cytokines in human adipose-derived mesenchymal stem cells
por: Park, Seul-Ki, et al.
Publicado: (2014)

Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells
por: Jung, Yi-deun, et al.
Publicado: (2020)

Therapeutic Effect of Three-Dimensional Cultured Adipose-Derived Stem Cell-Conditioned Medium in Renal Ischemia-Reperfusion Injury
por: Kim, Yu Seon, et al.
Publicado: (2022)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic Efficacy
por: Jang, Myoung Jin, et al.
Publicado: (2018)

Comparison of Stromal Vascular Fraction and Adipose-Derived Stem Cells for Protection of Renal Function in a Rodent Model of Ischemic Acute Kidney Injury
por: Aum, Joomin, et al.
Publicado: (2022)

Efficacy and Safety of Human Bone Marrow-Derived Mesenchymal Stem Cells according to Injection Route and Dose in a Chronic Kidney Disease Rat Model
por: Chae, Han Kyu, et al.
Publicado: (2022)

Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats
por: Kim, Jong Keun, et al.
Publicado: (2020)

Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
por: Park, Jee Soo, et al.
Publicado: (2020)

Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
por: Park, Arum, et al.
Publicado: (2019)

miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells
por: Vahabi, Mahrou, et al.
Publicado: (2019)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index
por: Lee, Chunwoo, et al.
Publicado: (2011)

Primary Malignant B-cell Lymphoma of the Epididymis
por: Suh, Jungyo, et al.
Publicado: (2015)

Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
por: Park, Yong Hyun, et al.
Publicado: (2014)

In vitro, in vivo, and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases
por: Kim, Dai Hee, et al.
Publicado: (2018)

Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
por: Alifrangis, C, et al.
Publicado: (2016)

A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways
por: Kim, Yunlim, et al.
Publicado: (2023)

New drugs in prostate cancer
por: Yoo, Sangjun, et al.
Publicado: (2016)

Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB
por: Park, Sang Eun, et al.
Publicado: (2016)

Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB
por: Park, Sang Eun, et al.
Publicado: (2019)

A Newly Developed Hematuria Grading System May Predict the Status of Stone-Free and Acute Pyelonephritis of Minimally Invasive Renal Stone Surgery
por: Kim, Gyeong Hun, et al.
Publicado: (2023)

Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis
por: Jang, Gwan, et al.
Publicado: (2020)

Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
por: You, Dalsan, et al.
Publicado: (2015)

miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK–PTEN axis
por: Jing, Zhi-Fei, et al.
Publicado: (2019)

KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway
por: You, Dalsan, et al.
Publicado: (2015)

Cytologic Findings of Clear Cell Adenocarcinoma of the Urethra: A Case Report
por: Han, Jee-Young, et al.
Publicado: (2012)

Correction: KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway
por: You, Dalsan, et al.
Publicado: (2019)

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
por: Tsuchiya, Norihiko, et al.
Publicado: (2014)

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Shibasaki, Noboru, et al.
Publicado: (2015)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
por: Dufies, Maeva, et al.
Publicado: (2017)

Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma
por: Nagase, Kei, et al.
Publicado: (2021)

Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?
por: Yoo, Sagnjun, et al.
Publicado: (2021)

Bowel perforation associated sunitinib therapy for recurred gastric gastrointestinal stromal tumor
por: Kim, Hyo-Sin, et al.
Publicado: (2014)

Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2013)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
por: Pak, Sahyun, et al.
Publicado: (2022)

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
por: Powles, T., et al.
Publicado: (2011)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

Angiosarcoma of the Retroperitoneum: Report on a Patient Treated with Sunitinib
por: Yoo, Changhoon, et al.
Publicado: (2009)

Bladder wall thickness and detrusor wall thickness can help to predict the bladder outlet obstruction in men over the age of 70 years with symptomatic benign prostatic hyperplasia
por: Park, Juhyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7548c5497ka4lhj8cp76lps2t0